Dr. Raphael See, MD

Dr. See practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. See's NPI, 1639362171, was assigned on August 18, 2007. Dr. See graduated from University of Texas Southwestern Medical School at Dallas in 2003. Dr. See holds Tennessee license 43365.

Dr. See's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. See's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. Dr. See is also affiliated with Vanderbilt Clarksville Hospital. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. See to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. See practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. See's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. See is licensed in Tennessee.

CMS data shows 3,993 Medicare services from Dr. See across 21 procedure codes in 2024, for 2,843 Medicare patients. Medicare paid $94,511 for them.

CMS counts 2,843 Medicare patients who saw Dr. See in 2024. The largest group is 65 to 74, with 1,265 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. See's median patient age at 68, with 51% women.

In 2024, Dr. See wrote 4,541 Medicare Part D claims for 585 patients. 82% of them were for generic drugs. CMS names the drug for 4,255 of them, across 54 drugs with 11 or more claims each, at $817,842 in total drug cost. In 2023, CMS named 4,042 claims across 54 drugs.

Dr. See accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. See as offering telehealth.

Dmand AI links 8 papers to Dr. See, published from 2011 to 2024. 2011 was the busiest year, with 2. Dr. See has published most often in Ir Med J. Dr. See's most frequent co-authors are Darren Keith McGuire, MD, James Andrew De Lemos, MD and Shuaib Abdullah, MD.

Dr. See graduated from University of Texas Southwestern Medical School at Dallas in 2003.